articleTop 1% cited
Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Annals of Oncology · 2018 · Vol. 29(Suppl 4) · pp. iv238–iv255
Arndt Vogel✉(Medizinische Hochschule Hannover)Andrés Cervantes(Universitat de València)Ian Chau(Royal Marsden Hospital)Bruno Daniele(Azienda Ospedaliera G.Rummo)Josep M. Llovet(Institució Catalana de Recerca i Estudis Avançats)Tim Meyer(CRUK Lung Cancer Centre of Excellence)Jean‐Charles Nault(Hôpital Jean-Verdier)Ulf P. Neumann(RWTH Aachen University)Jens Ricke(Ludwig-Maximilians-Universität München)Bruno Sangro(Clinica Universidad de Navarra)Peter Schirmacher(Heidelberg University)Chris Verslype(Universitair Ziekenhuis Leuven)Francis Zech(University of Basel)Dirk Arnold(Asklepios Klinik Altona)Erika Martinelli(University of Campania "Luigi Vanvitelli")
Hepatocellular Carcinoma Treatment and PrognosisLiver Disease Diagnosis and TreatmentHepatitis B Virus StudiesMedicineHepatocellular carcinomaIncidence (geometry)CancerLiver cancerInternal medicineHepatitis BCarcinomaViral hepatitisDemography
MeSH terms
SurvivorshipAftercareAntineoplastic Combined Chemotherapy ProtocolsBrachytherapyEuropeFatty LiverHepatectomyCarcinoma, HepatocellularHumansLiverLiver CirrhosisLiver NeoplasmsMass ScreeningMedical OncologyNeoplasm Staging
Citations
1,047
FWCI
49.65
field-weighted impact
References
136
Percentile
100%
vs. same field & year
Citations per year
Cited by
BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update
Journal of Hepatology · 2021 · 3,953 citations
References
Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
International Journal of Cancer · 2014 · 28,948 citations
Sorafenib in Advanced Hepatocellular Carcinoma
New England Journal of Medicine · 2008 · 12,835 citations
Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival
Hepatology · 2003 · 3,004 citations
Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial
The Lancet Oncology · 2008 · 5,801 citations
Phase III study of sorafenib after transarterial chemoembolisation in Japanese and Korean patients with unresectable hepatocellular carcinoma
European Journal of Cancer · 2011 · 570 citations
Expanding the natural history of nonalcoholic steatohepatitis: From cryptogenic cirrhosis to hepatocellular carcinoma
Gastroenterology · 2002 · 1,434 citations
Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma
Hepatology · 2002 · 2,609 citations
A clinical trial of CTLA-4 blockade with tremelimumab in patients with hepatocellular carcinoma and chronic hepatitis C
Journal of Hepatology · 2013 · 982 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.
